Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ$2.93
Market Cap
$250.59M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
308 of 918
Rank in Industry
178 of 522
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
AVIR Insider Trading Activity
AVIR Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $81,499 | 2 | 25 |
Sells | $1,322,798 | 6 | 75 |
Related Transactions
| BERGER FRANKLIN M | director | 2 | $81,499 | 1 | $1.02M | $-941,976 |
| Polsky Bruce | director | 0 | $0 | 1 | $61,144 | $-61,144 |
| Sommadossi Jean-Pierre | President, CEO, and Chairman | 0 | $0 | 4 | $238,179 | $-238,179 |
About Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The company also develops AT-752, an oral purine nucleoside prodrug product candidate, which has completed Phase Ia clinical trial for the treatment of dengue; AT-777, an NS5A inhibitor; AT-787, a …
Insider Activity of Atea Pharmaceuticals, Inc.
Over the last 12 months, insiders at Atea Pharmaceuticals, Inc. have bought $81,499 and sold $1.32M worth of Atea Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Atea Pharmaceuticals, Inc. have bought $4.39M and sold $675,139 worth of stock each year.
Highest buying activity among insiders over the last 12 months: BERGER FRANKLIN M (director) — $81,499.
The last purchase of 10,000 shares for transaction amount of $33,614 was made by BERGER FRANKLIN M (director) on 2025‑01‑16.
List of Insider Buy and Sell Transactions, Atea Pharmaceuticals, Inc.
| 2025-01-16 | BERGER FRANKLIN M | director | 10,000 0.0119% | $3.36 | $33,614 | -6.91% | ||
| 2025-01-15 | BERGER FRANKLIN M | director | 15,000 0.0175% | $3.19 | $47,885 | -6.63% | ||
| 2024-12-10 | Sale | BERGER FRANKLIN M | director | 359,606 0.42% | $2.85 | $1.02M | +6.80% | |
| 2024-09-19 | Sale | Sommadossi Jean-Pierre | President, CEO, and Chairman | 1,841 0.0026% | $4.00 | $7,368 | -15.71% | |
| 2024-09-18 | Sale | Sommadossi Jean-Pierre | President, CEO, and Chairman | 22,187 0.031% | $4.03 | $89,469 | -19.30% | |
| 2024-09-17 | Sale | Sommadossi Jean-Pierre | President, CEO, and Chairman | 33,941 0.0475% | $4.05 | $137,319 | -19.65% | |
| 2024-06-20 | Sale | Polsky Bruce | director | 17,544 0.0212% | $3.49 | $61,144 | -2.05% | |
| 2024-06-05 | Sale | Sommadossi Jean-Pierre | President, CEO, and Chairman | 1,006 0.0014% | $4.00 | $4,024 | -15.40% | |
| 2024-02-01 | Sale | Corcoran Andrea | See Remarks | 15,843 0.0211% | $3.84 | $60,915 | -13.98% | |
| 2024-02-01 | Sale | Sommadossi Jean-Pierre | President, CEO, and Chairman | 56,910 0.0758% | $3.85 | $218,819 | -13.98% | |
| 2024-02-01 | Sale | Hammond Janet MJ | Chief Development Officer | 14,029 0.0187% | $3.84 | $53,913 | -13.98% | |
| 2024-02-01 | Sale | Horga Maria Arantxa | Chief Medical Officer | 15,870 0.0211% | $3.84 | $60,963 | -13.98% | |
| 2024-02-01 | Sale | Vavricka John | Chief Commercial Officer | 11,819 0.0157% | $3.84 | $45,420 | -13.98% | |
| 2024-02-01 | Sale | Foster Wayne | EVP, Chief Accounting Officer | 12,477 0.0166% | $3.84 | $47,904 | -13.98% | |
| 2022-11-14 | Sale | BERGER FRANKLIN M | director | 16,166 0.0289% | $5.16 | $83,352 | -31.57% | |
| 2022-11-11 | Sale | BERGER FRANKLIN M | director | 25,500 0.0455% | $5.15 | $131,333 | -32.40% | |
| 2021-12-20 | Murphy Polly A. | director | 12,000 0.0356% | $8.57 | $102,796 | -21.40% | ||
| 2020-11-03 | Hack Andrew A. F. | director | 250,000 2.0771% | $24.00 | $6M | +10.66% | ||
| 2020-11-03 | Rock Springs Capital Management LP | 10 percent owner | 250,000 2.0771% | $24.00 | $6M | +10.66% | ||
| 2020-11-03 | BERGER FRANKLIN M | director | 41,666 0.3462% | $24.00 | $999,984 | +10.66% |
Total: 20
*Gray background shows transactions not older than one year
Insider Historical Profitability
<0.0001%
| BERGER FRANKLIN M | director | 476897 0.5576% | $1.4M | 3 | 3 | |
| Hack Andrew A. F. | director | 5615659 6.5661% | $16.45M | 1 | 0 | |
| Rock Springs Capital Management LP | 10 percent owner | 1654724 1.9348% | $4.85M | 1 | 0 | |
| Murphy Polly A. | director | 23295 0.0272% | $68,254.35 | 1 | 0 | <0.0001% |
*Gray background shows insiders who have made transactions during last year
Historical Insider Profitability vs. Competitors
$7,201,783 | 88 | -8.61% | $244.68M | |
$69,130,029 | 69 | 25.63% | $243.53M | |
$18,554,304 | 31 | -11.72% | $245.25M | |
$41,446,394 | 27 | 12.91% | $275.18M | |
$56,550,550 | 22 | 50.17% | $254.91M |
AVIR Institutional Investors: Active Positions
| Increased Positions | 53 | +46.09% | 3M | +5.46% |
| Decreased Positions | 47 | -40.87% | 5M | -8.24% |
| New Positions | 15 | New | 772,644 | New |
| Sold Out Positions | 17 | Sold Out | 784,989 | Sold Out |
| Total Postitions | 121 | +5.22% | 56M | -2.77% |
AVIR Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Blackrock, Inc. | $29,180.00 | 10.54% | 9.06M | +71,447 | +0.8% | 2024-12-31 |
| Bml Capital Management, Llc | $24,499.00 | 8.85% | 7.61M | +958,312 | +14.41% | 2024-12-31 |
| Fmr Llc | $20,689.00 | 7.47% | 6.43M | -193,072 | -2.92% | 2024-12-31 |
| Tang Capital Management Llc | $15,420.00 | 5.57% | 4.79M | +181,852 | +3.95% | 2024-12-31 |
| Vanguard Group Inc | $15,027.00 | 5.43% | 4.67M | -184,364 | -3.8% | 2024-12-31 |
| Ecor1 Capital, Llc | $10,760.00 | 3.89% | 3.34M | -2M | -38.59% | 2024-12-31 |
| Bain Capital Life Sciences Investors, Llc | $8,004.00 | 2.89% | 2.49M | 0 | 0% | 2024-12-31 |
| Geode Capital Management, Llc | $6,172.00 | 2.23% | 1.92M | -7,987 | -0.41% | 2024-12-31 |
| State Street Corp | $5,751.00 | 2.08% | 1.79M | +52,592 | +3.03% | 2024-12-31 |
| Renaissance Technologies Llc | $3,917.00 | 1.42% | 1.22M | +9,500 | +0.79% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.